new glp-1 drugs in development A wave of weight-loss therapies aims to be better than today's GLP-1s Upcoming wave of hormone-based therapies

However, when combined with insulin or sulfonylureas, hypoglycemia risk increases, and dose adjustments of these concomitant medications may be necessary

Not a miracle cure, but a toolone that could help tip the scales (see what I did there?) in favor of recovery

9 kg), reduces depression scores and improves QoL dimensions such as mood and self-image, with changes correlating with the magnitude of weight loss (138)

Additionally, limiting alcohol consumption in the days leading up to your start date is wise, as alcohol can exacerbate dehydration and interfere with blood sugar stabilization during the initial phase of treatment

Andrew Dillin, quoted in this New York Times article on rapamycin, thinks not: Why take risks with unproven benefits? he told The Times